Anesthesiology Doctors in Waconia, MN Accepting Medicare

8 Anesthesiology doctors found. Showing 1 - 8

Jule R Block, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-7015    Fax: 952-442-7016

Dr. Mark Christopher Reiner, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-2191

Paul J Savaryn, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-7015    Fax: 952-442-7016

John A Hill, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-7015    Fax: 952-442-7016

John H Merideth Jr., MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 29 E Main St, Waconia, MN 55387 Phone: 952-442-7015    Fax: 952-442-7016

Igor P Ostanny, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-7015    Fax: 952-442-7016

James M Turner, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-7015    Fax: 952-442-7016

Kent J Forss, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-7015    Fax: 952-442-7015

News Archive

Scientists discover new infection route for influenza A viruses

The immunologically relevant MHC class II molecules are ubiquitously found in many animal species, which is why the discovery will play an important role in assessing the risk of spill-over infections to other species than bats.

Researchers assess effects of adding dapagliflozin to metformin or insulin in type 2 diabetes patients

Researchers used continuous glucose monitoring to assess the effects of adding dapagliflozin to a regimen of either metformin or insulin in patients with type 2 diabetes and found significant reductions in mean glucose and other glycemic factors, with greater improvements seen in patients taking metformin compared to insulin.

Atopix recruits first patient in OC459 Phase 2 trial for treatment of atopic dermatitis

Atopix Therapeutics Ltd, a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the recruitment of the first patient in a six month Phase 2 clinical trial of its lead compound OC459 in moderate-to-severe atopic dermatitis (eczema).

Novel tiny spectrometer can detect food quality

Whether fruit, meat or cheese - the quality of food is not always as consumers would like it to be. But, in future, a spectrometer will allow them to gage the quality of food before they buy it. No bigger than a sugar cube, the device is inexpensive to manufacture and could one day even be installed in smartphones.

Read more Medical News

› Verified 5 days ago